MERCK Kommanditgesellschaft auf Aktien
MER
Clasificación en acciones
#323
Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the... Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
Precio por acción
$171.67
Última sincronización: 2026-07-13
Capitalización bursátil
$74.64B
Cambio (1 día)
0.00%
Cambio (1 año)
-
País
DE
Comercio MERCK Kommanditgesellschaft auf Aktien (MER)
Categoría
Healthcare
Ganancias de MERCK Kommanditgesellschaft auf Aktien (MER)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di MERCK Kommanditgesellschaft auf Aktien, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de MERCK Kommanditgesellschaft auf Aktien desde 2002 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2025 | $3.88B | -15.61% |
| 2022 | $4.60B | 3.06% |
| 2021 | $4.46B | 39.31% |
| 2020 | $3.20B | 64.54% |
| 2019 | $1.95B | 15.95% |
| 2018 | $1.68B | -37.09% |
| 2017 | $2.67B | 17.75% |
| 2016 | $2.27B | 40.42% |
| 2015 | $1.61B | -14.32% |
| 2014 | $1.88B | -1.34% |
| 2013 | $1.91B | 104.18% |
| 2012 | $935.24M | -15.11% |
| 2011 | $1.10B | -4.30% |
| 2010 | $1.15B | 65.07% |
| 2009 | $697.43M | -12.95% |
| 2008 | $801.20M | -594.25% |
| 2007 | $-162.10M | -109.67% |
| 2006 | $1.68B | 58.74% |
| 2005 | $1.06B | -18.97% |
| 2004 | $1.30B | 144.81% |
| 2003 | $532.17M | 23.21% |
| 2002 | $431.92M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
|
| - | - |
CN
|
